Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Heparin recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Heparin (118 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Heparin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Heparin recalls on record

none so far in 2026; 118 on record, newest first
Class I · High risk

Heparin Sodium 10

Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

Terminated Cross-contamination SCA Pharmaceuticals D-1553-2020
Class I · High risk

Heparin Sodium 5

Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

Terminated Cross-contamination SCA Pharmaceuticals D-1552-2020
Class I · High risk

Heparin Sodium 5

Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

Terminated Cross-contamination SCA Pharmaceuticals D-1551-2020
Class I · High risk

Heparin Sodium 2

Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.

Terminated Cross-contamination SCA Pharmaceuticals D-1550-2020
Class II · Moderate risk

Heparin Sodium 5

Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.

Terminated Wrong potency / content SCA Pharmaceuticals NDC 70004-0650-46 D-1495-2020
Class II · Moderate risk

Heparin Sodium 5

Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.

Terminated Wrong potency / content SCA Pharmaceuticals NDC 70004-0650-46 D-1311-2020
Class II · Moderate risk

Heparin Sodium 25

Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications.

Terminated Wrong potency / content B. Braun Medical Inc NDC 0264-9587-20 D-1343-2019
Class II · Moderate risk

Heparin 20

Lack of sterility assurance.

Terminated Sterility / contamination Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1191-2019
Class II · Moderate risk

Heparin 10

Lack of sterility assurance.

Terminated Sterility / contamination Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1158-2019
Class II · Moderate risk

Heparin 20

Lack of sterility assurance.

Terminated Sterility / contamination Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy D-1156-2019
Class II · Moderate risk

HEPERAIN 50 mg/50 mL

Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL)

Terminated Labeling / mix-up Advanced Pharma Inc. D-0430-2019
Class II · Moderate risk

Heparin 1

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 42852-747-25 D-0948-2018
Class II · Moderate risk

Heparin 12

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 42852-745-25 D-0947-2018
Class II · Moderate risk

Heparin 25

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 42852-729-25 D-0934-2018
Class II · Moderate risk

Heparin sodium all strengths

Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

Terminated Labeling / mix-up Advanced Pharma Inc. D-0822-2017